Lack of clean water, sanitation, and hygienic controls in Cambodia promotes emergence of drug-resistant E. coli

A new study suggests that Escherichia coli and other disease-causing microbes are passing easily between humans and animals in Cambodia, a country where clean water, sanitation and hygienic controls are lacking in many regions.

Neonatal ICU mystery: Unraveling the secrets of the prevalent Staphylococcus strain

Researchers delve into the genomes of Staphylococcus capitis isolates prevalent in neonates, revealing transmission patterns and survival tactics of the NRCS-A strain in neonatal ICUs.

October 8, 2023

Vanda buys J&J’s multiple sclerosis drug Ponvory for $100M

Vanda Pharmaceuticals has paid $100 million to Actelion Pharmaceuticals, a Johnson & Johnson company, for the US and Canada rights to multiple sclerosis drug Ponvory.

December 8, 2023

ARIA-E risk of Lilly’s Kisunla reduced with modified dosing

Eli Lilly will be submitting the data on the modified dosing regime of Kisunla to global regulators. Image credit: Tada Images / Shutterstock. A modified

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.